Human lung cancer cells harboring wt-TP53 have higher DOC sensitivity than cells harboring abnormal TP53. Whereas, human lung cancer cells harboring abnormal TP53 have higher lovastatin sensitivity than cells harboring wt-TP53. Here, TP53 is linked to lung cancer.